盟科药业-U
(688373)
| 流通市值：22.62亿 | | | 总市值：40.52亿 |
| 流通股本：3.66亿 | | | 总股本：6.56亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 392,741,663.34 | 386,262,631.61 | 254,014,785.61 | 148,462,125.93 |
| 应收票据及应收账款 | 34,211,494.07 | 31,878,371.44 | 30,597,934.17 | 23,753,117.18 |
| 应收账款 | 34,211,494.07 | 31,878,371.44 | 30,597,934.17 | 23,753,117.18 |
| 预付款项 | 14,716,156.26 | 18,737,536.57 | 33,267,259.22 | 30,518,666.74 |
| 其他应收款合计 | 24,056,967.29 | 21,019,751.21 | 213,329.1 | 306,413.6 |
| 存货 | 52,085,719.68 | 52,936,424 | 45,452,339.78 | 42,589,170.63 |
| 其他流动资产 | 32,066,077.54 | 30,470,693.12 | 19,364,289.24 | 22,327,038.09 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 757,668,471.24 | 748,661,957.2 | 869,192,299.77 | 896,380,052.57 |
| 非流动资产: | | | | |
| 固定资产 | 5,277,875.94 | 5,824,313.36 | 6,314,160.63 | 6,797,410.85 |
| 使用权资产 | 66,841,232.53 | 69,974,353.53 | 69,779,846.71 | 73,277,083.57 |
| 无形资产 | 1,546,731.19 | 1,680,076.79 | 1,760,954.87 | 1,809,254.39 |
| 长期待摊费用 | 18,334,909.32 | 19,099,135.89 | 19,502,883.76 | 20,096,541.27 |
| 其他非流动资产 | 3,914,207.75 | 3,888,822.85 | 4,199,470.25 | 4,489,894.91 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 95,914,956.73 | 100,466,702.42 | 101,557,316.22 | 106,470,184.99 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 853,583,427.97 | 849,128,659.62 | 970,749,615.99 | 1,002,850,237.56 |
| 流动负债: | | | | |
| 短期借款 | 5,000,000 | 5,000,000 | - | - |
| 应付票据及应付账款 | 80,483,709.07 | 74,776,456.31 | 73,075,444.47 | 59,339,424.55 |
| 应付账款 | 80,483,709.07 | 74,776,456.31 | 73,075,444.47 | 59,339,424.55 |
| 应付职工薪酬 | 6,806,192.34 | 12,190,904.75 | 12,368,608.19 | 8,840,092.31 |
| 应交税费 | 12,438,844.1 | 10,200,093.95 | 1,366,431.26 | 902,633.99 |
| 其他应付款合计 | 9,944,840.21 | 9,387,188.2 | 10,542,316.23 | 8,425,326.41 |
| 一年内到期的非流动负债 | 128,442,537.02 | 100,741,940.01 | 30,674,626.71 | 30,914,374.09 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 243,116,122.74 | 212,296,583.22 | 128,027,426.86 | 108,421,851.35 |
| 非流动负债: | | | | |
| 长期借款 | 154,531,541.57 | 122,940,000 | 198,450,000 | 161,950,000 |
| 租赁负债 | 69,865,227.03 | 73,178,324.69 | 74,868,895.66 | 76,450,368.3 |
| 递延收益 | 1,750,000 | 1,750,000 | 1,750,000 | 1,400,000 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 226,146,768.6 | 197,868,324.69 | 275,068,895.66 | 239,800,368.3 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 469,262,891.34 | 410,164,907.91 | 403,096,322.52 | 348,222,219.65 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 655,605,491 | 655,605,491 | 655,210,084 | 655,210,084 |
| 资本公积 | 1,578,773,222.01 | 1,570,967,921.81 | 1,555,179,684.7 | 1,549,487,186.77 |
| 其他综合收益 | 16,265,797.55 | 17,081,837.14 | 12,529,951.91 | 15,205,275.1 |
| 未分配利润 | -1,866,323,973.93 | -1,804,691,498.24 | -1,655,266,427.14 | -1,565,274,527.96 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 384,320,536.63 | 438,963,751.71 | 567,653,293.47 | 654,628,017.91 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 384,320,536.63 | 438,963,751.71 | 567,653,293.47 | 654,628,017.91 |
| 负债和股东权益合计 | 853,583,427.97 | 849,128,659.62 | 970,749,615.99 | 1,002,850,237.56 |
| 公告日期 | 2025-04-24 | 2025-03-18 | 2024-10-25 | 2024-08-29 |
| 审计意见(境内) | | 标准无保留意见 | | |